Expansion into Ireland Astellas recently expanded its facilities to Ireland in September 2023 with a €330 million state-of-the-art facility construction in Tralee. This expansion indicates a growing presence and potential business opportunities in the region.

Digital Health Offering in the US Astellas has launched its first digital health offering in the US, providing a toolkit for at-home monitoring for individuals living with heart failure. This offering opens up opportunities for partnerships with healthcare providers and insurers in the digital health space.

Partnership with Mydohc Astellas partnered with Mydohc and announced Desert Oasis Healthcare as the first health system to implement DIGITIVA(TM) for heart failure management. This collaboration presents possibilities for further collaborations with healthcare organizations and systems.

Investment in AviadoBio Limited Astellas invested $30 million into AviadoBio Limited, a London-based company. This financial investment showcases Astellas' interest in innovative biotech solutions and signifies potential future collaborations or acquisitions in the biotech sector.

Closure of Offices in South San Francisco Astellas closed its offices in South San Francisco, California, and a gene therapy manufacturing facility. This strategic move may lead to opportunities to reallocate resources and focus on optimizing operations in other locations or exploring new partnerships in different regions.